Tag Archives: Patients

FDA Approves Fotivda (tivozanib) for the Treatment of Adult Patients with Relapsed or Refractory Advanced Renal Cell Carcinoma

FDA Approves Fotivda (tivozanib) for the Treatment of Adult Patients with Relapsed or Refractory Advanced Renal Cell Carcinoma BOSTON–(BUSINESS WIRE) March 10, 2021 — AVEO Oncology (Nasdaq: AVEO) today announced that the U.S. Food and Drug Administration (FDA) has approved Fotivda (tivozanib) for the treatment of adults with relapsed or refractory advanced renal cell carcinoma… Read More »

ESMO: Merck’s Keytruda doubles 5-year survival rate for lung cancer patients

Immuno-oncology competition has mounted this year in previously untreated, metastatic non-small cell lung cancer. But Merck’s Keytruda, the first PD-1/PD-L1 on the market in the setting, has new long-term survival results that the drugmaker hopes will help bolster its position. Keytruda doubled the five-year survival rate for patients whose tumors expressed levels of biomarker PD-L1… Read More »

Mass. General tests new therapy for pregnant coronavirus patients

Inhaled NO increases oxygenation by dilating or opening constricted blood vessels, especially in more well-ventilated areas of the lung, thereby improving intrapulmonary shunt fraction, or the percentage of blood put out by the heart that is not completely oxygenated. A recent report from the Centers for Disease Control and Prevention (CDC) suggests that pregnant women… Read More »

‘Signatures’ in blood reveal how sepsis patients will respond to condition

Scientists have identified molecular “signatures” in the immune component of the blood which indicate how patients in intensive care with sepsis, septic shock and systemic inflammatory response syndrome are likely to respond to the conditions. The work – led by Public Health England and involving Cardiff and Nottingham Trent universities – means that for the… Read More »